Results 11 to 20 of about 62,734 (244)

Ten Years of Experience in Treating Patients With Digoxin Toxicity Without Using Digoxin Fab Antibody

open access: yesInternational Journal of Medical Toxicology and Forensic Medicine, 2021
Background: Digoxin is extensively prescribed for cardiac diseases, so its chronic or acute toxicity commonly occur. Although digoxin specific antibodies (anti-digoxin Fab) are recommended to be used in patients with cardiac ...
Farzad Gheshlagh   +7 more
doaj   +1 more source

Review: Failure of current digoxin monitoring for toxicity: new monitoring recommendations to maintain therapeutic levels for efficacy

open access: yesFrontiers in Cardiovascular Medicine, 2023
The current recommendations for monitoring digoxin, a narrow therapeutic index drug, are limited to confirming medication use or investigating suspicion of toxicity and fail our oath to do no harm.
Sridhar Rao Gona   +5 more
doaj   +1 more source

The cardiac work-loop technique:An in vitro model for identifying and profiling drug-induced changes in inotropy using rat papillary muscles [PDF]

open access: yes, 2020
The cardiac work-loop technique closely mimics the intrinsic in vivo movement and characteristics of cardiac muscle function. In this study, six known inotropes were profiled using the work-loop technique to evaluate the potential of this method to ...
AJ Taberner   +56 more
core   +1 more source

Interaction between Chinese medicine and digoxin: Clinical and research update

open access: yesFrontiers in Pharmacology, 2023
Background: Digoxin is one of the most widely and commonly used cardiac drug, which plays an irreplaceable role in treating heart failure and arrhythmia.
Wei Zhuang   +6 more
doaj   +1 more source

Clinical signs and symptoms of toxic serum digoxin levels in neonates

open access: yesThe Turkish Journal of Pediatrics, 2019
Digoxin is widely used in the treatment of congestive heart failure and some arrhythmias. Digoxin toxicity may occur easily because digoxin has a narrow therapeutic index.
Mehmet Mutlu   +4 more
doaj   +1 more source

The Effects of Pregnenolone 16α-Carbonitrile Dosing on Digoxin Pharmacokinetics and Intestinal Absorption in the Rat [PDF]

open access: yes, 2010
The effect of Pgp induction in rats by pregnenolone 16α-carbonitrile (PCN) (3 days, 35 mg/kg/d, p.o.) on digoxin pharmacokinetics and intestinal transport has been assessed.
Anna-Lena Ungell   +12 more
core   +2 more sources

Labeless and reversible immunosensor assay based upon an electrochemical current-transient protocol [PDF]

open access: yes, 2003
A novel labeless and reversible immunoassay based upon an electrochemical current-transient protocol is reported which offers many advantages in comparison to classical immuno-biochemical analyses in terms of simplicity, speed of response, reusability
Davis, Frank   +5 more
core   +1 more source

A 5 years assessment of patients with acute digoxin poisoning: A toxicoepidemiology study in Iran

open access: yesHeart Views, 2021
Background: Digoxin poisoning leads to the development of cardiac and noncardiac complications. Digoxin immune fab is a safe and effective antidote, but clinical trials have not been performed in this regard, and most of the evidence is based on ...
Mitra Rahimi   +3 more
doaj   +1 more source

Characterisation of the Na, K pump current in atrial cells from patients with and without chronic atrial fibrillation [PDF]

open access: yes, 2003
<b>Objective:</b> To assess the contribution of the Na, K pump current (<i>I</i><sub>p</sub>) to the action potential duration (APD) and effective refractory period (ERP) in human atrial cells, and to investigate ...
Kane, K.A., Rankin, A.C., Workman, A.J.
core   +1 more source

Pharmacokinetics, Safety, and Efficacy of Intravitreal Digoxin in Preclinical Models for Retinoblastoma [PDF]

open access: yes, 2015
PURPOSE:To assess in vitro cytotoxic activity and antiangiogenic effect, ocular and systemic disposition, and toxicity of digoxin in rabbits after intravitreal injection as a potential candidate for retinoblastoma treatment.METHODS:A panel of two ...
Abramson, David   +13 more
core   +2 more sources

Home - About - Disclaimer - Privacy